• Home/
  • Middle East/
  • Ukraine Slams Russia Over Kusum Pharma Strike: ‘An Attempt to Justify Terror’

Ukraine Slams Russia Over Kusum Pharma Strike: ‘An Attempt to Justify Terror’

Ukraine rejects Russia’s claim on the Kusum Pharma strike, calling it cynical, incompetent, and legally flawed.

Advertisement · Scroll to continue
Advertisement · Scroll to continue
Ukraine Slams Russia Over Kusum Pharma Strike: ‘An Attempt to Justify Terror’

Ukraine and Russia remain at loggerheads over Russia’s recent claim of blame-shifting after this week’s missile strike which bombed an Indian drugs warehouse in the Ukrainian capital of Kyiv.

As Russia lays blame, Ukraine terms the reason legally flawed and morally egregious. Both nations are trying to promulgate dueling narratives and India is left in the crosshairs diplomatically. The controversy puts crucial questions before them regarding civilian security, wartime accountability, and expanding risks to foreign companies in combat zones.

Russia dismissed attacking Kusum Pharma’s plant. It blamed Ukraine’s defenses for causing the blaze by accident.

The Russian Embassy in New Delhi said no Russian missile struck civilian targets. The damage could have been caused by fragments from a Ukrainian missile, according to them.

Ukraine Criticizes Russia’s Account

Ukraine had a rapid comeback. The Embassy of Ukraine in New Delhi averred that Moscow’s account had made a jest of international law. “Every attempt to legitimise terror would be legally non-viable, cynical in its nature, and pathetic in execution,” the embassy said.

It also accused the Russian capital city of feigning to “plan airstrikes with precision”—yet, in truth, the attacks frequently target non-combatant populations.

Ukrainian authorities opened a criminal inquiry into the attack. They want to punish those accountable for it. Kyiv asserts the Russian missile hit the pharmaceutical warehouse directly, killing one Indian employee and wounding others.

India Looks on with Caution

India has not yet accused either of the two nations. But the incident has placed added pressure on New Delhi to react. Indian companies are working in Ukraine, and there are rising concerns over safety. The attack can provoke firms to rethink their presence within conflict zones.

Kusum Pharma’s loss points to larger risks for foreign firms in unstable areas. As the war continues, such events may become more common. Firms now risk not only market volatility—but loss of life and infrastructure.